Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$28.08 -1.02 (-3.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Accumulated Depreciation (2021 - 2025)

Updated

Amylyx Pharmaceuticals (AMLX) recorded Accumulated Depreciation of $1.55 million in Q4 2025, up 14.3% from $1.36 million a year earlier.

Analysis

Amylyx Pharmaceuticals (AMLX) Accumulated Depreciation (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Amylyx Pharmaceuticals' Accumulated Depreciation history includes 5 quarters.

  • Annual Accumulated Depreciation has a four-year compound annual growth rate of 132.7% (FY2021 to FY2025).
  • Across earlier years, Accumulated Depreciation came in at $1.36 million in FY2024 (-16.5%), $1.63 million in FY2023 (+201.5%), $540,000 in FY2022 (+918.9%) and $53,000 in FY2021.
  • The Q4 2025 figure is the highest quarterly Accumulated Depreciation since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Amylyx Pharmaceuticals 3.24 Bn 3.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Dec 31, 2024 1.36 Mn
Dec 31, 2023 1.63 Mn
Dec 31, 2022 540,000.00
Dec 31, 2021 53,000.00
API Access

Amylyx Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=AMLX&period=max&api_key=YOUR_API_KEY